Thierry Dervieux PharmD, PhD
Dr. Dervieux serves as Chief Development Officer, Diagnostics at Prometheus Biosciences. Previously Dr. Dervieux was at Exagen Diagnostics, a diagnostic company focused on chronic autoimmune diseases, where he served as Chief Scientific Officer, Medical Director. Prior to joining Exagen, Dr. Dervieux was Vice President of Research and Development at Cypress Bioscience, Inc. and Senior Director Research and Development with Proprius Pharmaceuticals, Inc. Prior to that, he served as Principal Scientist and Director of Research and Development at Prometheus Laboratories. Dr. Dervieux is board certified by the American Board of Clinical Chemistry and holds certificates of qualification as medical laboratory director in the categories of cellular immunology, clinical chemistry, drug monitoring, genetic testing and diagnostic immunology. Dr. Dervieux holds Pharm.D. and Ph.D. degrees from Claude Bernard University in Lyon, France, an inter-university diploma in biostatistics from the University of Pierre and Marie Curie University in Paris, France, and trained at St. Jude Children’s Research Hospital in Memphis, Tennessee.